Gwyneth Paltrow has predicted the next wellness trend coming our way: psychedelics. Making the prediction during an interview with The New York Times, the Oscar-winning actress and founder of lifestyle company Goop gave the surprising answer, explaining: “I think how psychedelics affect health and mental health and addiction will come more into the mainstream.”
Paltrow – who stressed that she’s never actually tried psychedelics due to being “terrified” of them – does, however, have an interest in their effect on the human mind. “I mean there’s undeniably some link between being in that state and being connected to some other universal cosmic something,” Paltrow said. Psychedelics are drugs known to produce hallucinations and alter the state of consciousness.
Paltrow specifically mentioned only one type of psychedelic during the interview: “ibogaine, that shrub from Gabon”. Ibogaine, is a psychoactive substance found in the roots of a plant located in Gabon in Africa. Maybe Paltrow will reveal more in London later this year at the brand’s In Goop Health wellness summit in June. The event will include panel talks, fitness classes and discussions involving alternative medicines. “Goop was born in London and it’s always been sort of a second home,” Goop’s chief content officer, Elise Loehnen, told Vogue following the announcement last year. “People are really interested and curious and there is probably equal interest in wellness in London [as there is in LA] which is not yet matched by what’s available. It was a no-brainer to bring In Goop Health to London.”